Document 0625 DOCN M94A0625 TI HIV-1 auxiliary protein Nef down-regulates expression of cellular receptors and factors involved in signalling. DT 9412 AU Greenway A; Allen K; McPhee D; AIDS Cellular Biology Unit, Macfarlane Burnet Centre, NCHVR,; Melbourne, Victoria, Australia. SO Annu Conf Australas Soc HIV Med. 1993 Oct 28-30;5:71 (abstract no. SB2). Unique Identifier : AIDSLINE ASHM5/94349030 AB The function of HIV-1 Nef protein, although poorly understood, has been implicated in the progression of HIV infection to AIDS. To address the effect of Nef on cellular activity, Nef protein was introduced into cells by a sophisticated electroporation technique. Electroporation of HIV-1 Nef reduced the expression of cell surface CD4 by 30-50%, as measured by flow cytometry, on phytohemagglutinin (PHA)-activated peripheral blood mononuclear cells (PBMC) as well as on a variety of CD4+ T-cell lines (MT-2. CEM and Jurkat). Reduction in surface CD4 was observed in all cells of the CD4+ T-cell lines but only in the CD4+ cells of the mixed PBMC population. Electroporation of Nef into MT-2 cells and PHA-activated PBMC also reduced the expression of CD25 to background levels. Other cell surface antigens such as CD2, CD7 or transferrin receptor were not affected by HIV-1 Nef. Levels of the proto-oncogene c-myb and phosphorylation of tyrosine kinase p56lck were also reduced in Nef-treated T-cell lines and PBMC. Thus, Nef has a significant effect on important host cell receptors and signalling pathways. Current investigations will delineate whether the down regulatory effect by Nef is a transcriptional or post-transcriptional event. DE Acquired Immunodeficiency Syndrome/*MICROBIOLOGY Cell Line Down-Regulation (Physiology)/GENETICS Gene Expression Regulation, Viral/PHYSIOLOGY Genes, nef/*GENETICS Human HIV Infections/*MICROBIOLOGY HIV-1/*GENETICS/PATHOGENICITY Monocytes/MICROBIOLOGY Receptors, HIV/*GENETICS Signal Transduction/*GENETICS Transcription, Genetic/GENETICS T4 Lymphocytes/MICROBIOLOGY Virus Integration/*GENETICS Virus Replication/*GENETICS MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).